Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating mental health integration in PrEP programs to reduce HIV incidence among US gay and bisexual men: a network modeling study.

BMC health services research·2026
Same author

Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Non-Hispanic Black Persons With HIV Have a Lower Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Clinically Significant Fibrosis Compared to Non-Hispanic White and Hispanic Individuals.

Open forum infectious diseases·2026
Same author

Trends in Coronavirus Disease 2019 Mortality Within a US Academic Health System, 2020-2025.

Open forum infectious diseases·2026
Same author

Improved understanding of pulmonary Mycobacterium avium treatment will arise from focusing on patients.

Annals of the American Thoracic Society·2026
Same author

Perspectives from Sri Lankan physicians on current approaches to diagnosing and managing lower respiratory tract infections.

BMC research notes·2026

Related Experiment Video

Updated: May 28, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Feasibility and willingness-to-pay for integrated community-based tuberculosis testing.

Neela D Goswami1, Emily Hecker, David P Holland

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. neela.goswami@duke.edu

BMC Infectious Diseases
|November 4, 2011
PubMed
Summary

Community-based screening for tuberculosis (TB), HIV, and syphilis faces barriers, with high-risk individuals placing low value on testing. Integrated testing programs require incentives and one-visit diagnostics for success.

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Related Experiment Videos

Last Updated: May 28, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Area of Science:

  • Public Health
  • Infectious Disease Control
  • Health Services Research

Background:

  • Community-based screening for TB, HIV, and syphilis is essential but faces significant barriers.
  • A key barrier identified is the perceived value of such integrated screening by the target communities.

Purpose of the Study:

  • To assess the value placed on integrated TB, HIV, and syphilis testing by high-risk populations.
  • To identify barriers and facilitators for community-based integrated screening programs.

Main Methods:

  • Integrated TB, HIV, and syphilis testing was conducted in high-risk neighborhoods identified via GIS mapping.
  • TB testing included skin tests and interferon-gamma release assays; surveys assessed risk factors, healthcare access, and willingness to pay.

Main Results:

  • Prevalent risk factors included prior incarceration (71%), crack cocaine use (27%), and homelessness (35%).
  • Willingness to pay for testing was low, with reported median payments decreasing significantly when presented in a multiple-choice format ($5 vs. $10-$20).
  • Low return rates for TB skin test results (18%) and HIV results (13%) were observed.

Conclusions:

  • High-risk individuals in this community outreach study demonstrated a low perceived value for integrated TB, HIV, and syphilis testing.
  • Reported willingness to pay likely overestimated actual willingness; incentives and one-visit testing are crucial for successful programs in these populations.